June 26, 2026

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

Conexiant

June 18, 2026

Cell Aging May Predict Future Disease

Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer,  and mortality across three large cohorts.

Conexiant

June 12, 2026

High-Dose Vitamin C Could Pose Risk in Severe Burns

“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”

Conexiant

June 11, 2026

FDA Clears Home Urine Collection Kit for STI Testing

The clearance enables a validated mail-in workflow for self-collected urine specimens processed on Roche cobas systems.

Conexiant

June 09, 2026

Salivary Marker May Reveal Sleep Deprivation

A machine-learning model distinguished samples collected following 1 night of total sleep deprivation from control and sleep-restriction conditions in a randomized crossover study of healthy young men.

Conexiant

June 08, 2026

Misdiagnosis Common in Parkinsonian Disorders

Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.

Conexiant

June 05, 2026

Congo Ebola Outbreak Strains Care Delivery

“We live with fear in our stomachs"

Kff Health News

June 01, 2026

Handwriting Kinematics Differentiate Cognitive Impairment

“Diagnostic differentiation emerged only under tasks imposing higher cognitive-motor demands.”

Conexiant

June 01, 2026

Troponin Testing and Early MI Discharge

Sixth-generation high-sensitivity cardiac troponin T assay classifies more patients below a low-risk threshold at presentation.

Conexiant

June 01, 2026

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

Conexiant